http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-524556-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9799ffcda2dbb45041a5ab0fd08dd5fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03C5-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03C1-83
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03C5-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03C1-83
filingDate 1938-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1940-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-524556-A
titleOfInvention Improvements in and relating to photographic materials and the processing thereof
abstract 524,556. Colour photography; photographic toning processes. KODAK, Ltd. (Eastman Kodak Co.). Oct. 26, 1938, No. 10273/40. Divided out of 524,500. Drawings to Specification. [Class 98 (ii)] [Also in Group IV] Photographic material has at least one image containing a silver salt of a coloured heterocyclic compound containing a chromophoric group and being in the heterocyclic nucleus an imino group which is next to or next but one to a nitrogen atom in the nucleus having an unshared pair of electrons. Azo derivatives of the heterocyclic compounds are suitable. Parent heterocyclic compounds specified are 1:2:3-triazole, 1:2:4- triazole, indazole, 2-mercapto-5-aminothiobiazole, thiohydantoin, ethylenethiourea, mercaptobenzimidazole, thiourazole, dihydroquinazoline, perimidine, imidazole, tetrazole, tetrazolone, 1:2:3-triazolin, and pyrazoleanthrone. These compounds may have additional substituents or fused-on rings, which may contain chromophoric or auxochrome groups. Specific examples of suitable compounds are 1-(benztriazole-4<SP>1</SP>-azo)-2-hydroxy-3-naphthoic acid, 4-phenylazo-5-aminoindazole, 1-(p nitrophenyl) - 3-methyl - 4 - (benztriazole - 4<SP>1</SP> - azo) - 5 - pyrazolone, 4-(p-hydroxyphenylazo)-benztriazole, 4-amino-7-(o-carboxyphenylazo)-benztriazole, 1 - benztriazole-4<SP>1</SP>-azo)- #-naphthol, 4-amino-7- phenylazobenztriazole, 4-(benztriazole-4<SP>1</SP>-azo)- 5-aminoindazole, 4-amino-7-(benztriazole-41- azo)-benztriazole, 5-amino-4-(o-carboxyphenylazo)-indazole, 5-p-hydroxyphenylazo)-indazole, and 1-hydroxy-2-(5-benztriazole azo)-8- amino-3:6-naphthalene disodium disulphonate. Developed silver images may be bleached to a relatively insoluble silver salt such as silver ferricyanide, orthophosphate, arsenate, arsenite, chloride, bromide, oxalate, or cyanate, and then toned to a more insoluble coloured silver salt by treatment with a dilute alkaline, such as a sodium carbonate, or hydroxide, solution of the imino compound. Acid solutions may be used. In an example, a developed silver image is removed with an acidified potassium permanganate solution or a dichromate solution and the residual silver halide image is tone red to magenta by treatment in a sodium carbonate solution of 4-amino-7-(o-carboxyphenylazo)- benztriazole. In another example a developed and fixed silver-image is bleached in a solution containing potassium ferricyanide and potassium bromide or chloride, is washed, and is toned yellow with a sodium carbonate solution of 4-(o-carboxyphenylazo)-5-aminoindazole. In another example, a three-layer film, which may be hardened and provided with permeable intermediate layers, is exposed, and developed and the developed silver removed, and the residual silver salt image in the top layer toned yellow by treatment in a sodium carbonate solution of 1-(p-nitrophenyl)-3-methyl-4-(benztriazole-4<SP>1</SP>-azo)-5-pyrazolone containing a loading agent, such as those described in Specification 454,622. After washing the middle image is toned magenta with a weakly alkaline solution of 1-(benztriazole-4<SP>1</SP>-azo )-#-naphthol, the film is washed, and the bottom image toned blue-green with a sodium carbonate solution of 1-hydroxy- 2- (5 - benztriazole azo) - 7 - (p-nitrophenylazo) - 8 - amino - 3:6 - naphthalene disodium-disulphonate. The intensity of the final image may be reduced by treatment with an alkaline hypo or dilute ammonium hydroxide solution. Partial toning may be effected. The coloured silver salt may be converted into the salt of another metal, such as copper, tin, lead, gold, or mercury, by treatment with a salt of such metal in a solution containing ammonia, ethanolamine, or sodium thiosulphate. The reversed images may be developed and bleached to salts such as silver phosphate, ferricyanide, arsenate, or oxalate before toning. These salts may be used as the light-sensitive salts. Specifications 440,032 and 524,500, are referred to. 5-Aminoindazole is prepared by the reduction by hydrogenation of 5-nitroindezole in the presence of finely divided nickel. 4- and 5- Aminobenztriazole are prepared similarly. 4- and 5-Nitrobenztriazole are prepared by treating a cold suspension of 3- or 4-nitro-1:2- diaminobenzene in concentrated hydrochloric acid with sodium nitrite. 4 - Amino - 7 - (bentriazole - 7<SP>1</SP> - azo) - benztriazole is prepared by coupling diazotized 4-aminobenztriazole with 4-aminobenztriazole. 4-Phenylazo-5-aminoindazole is prepared by coupling diazotizedanilinewith5-aminoindazo'e. 4 - Amino - 7 - (o-carboxyphenylazo) - benztriazole, 4 - amino - 7 - phenylazobenztriazole, 4 - (benztriazole - 4<SP>1</SP> - azo) - 5 - aminoindazole, and 5 - amino - 4 - (o-carboxyphenylazo) - indazole are similarly prepared using the appropriate diazo compound with either 4- amino benztriazole or 5 aminoidazole. 1-(Benztriazole-4<SP>1</SP>-azo)-2-hydroxy-3-naphthoic acid is prepared by the reaction of diazotized 4-aminobenztriazole on 2-hydroxy-3-naphthoic acid. 1-(p-Nitrophenyl)-3-methyl-4-(benztriazole-4<SP>1</SP>-azo)-5-pyrazoline, 4-(p-hydroxyphenylazo) - benztriazole, 1 - (benztriazole - 7<SP>1</SP> - azo)-#-naphthol, 5-(p-hydroxy phenylazo)- indazole, and 1-hydroxy-2-(5<SP>1</SP>-benztriazylazo 7 - (p-nitrophenylazo) - 8 - amino - 3:6 - naphthalene disodium disulphonate are similarly prepared by the reaction of diazotized 4- aminobenztriazole, 5-aminobenztriazole, or 5- aminoindazole with the appropriate coupling component. The Provisional Specification refers also to metallic salts of organic compounds in general in which the metal has replaced the hydrogen atom of an -SH or =NH group, and gives the following additional examples of metallic saltforming compounds ; 3-amino-4-(o-carboxyphenylazo) - phenol; α-carboxyphenylazorhodanine; 3 - carboxy - 4 - hydroxyphenylazorhodanine; 1-thiocarbamido - 3 - methyl - 4 - (o-carboxyphenylazo) - 5 - pyrazolone ; 1 - allylthiocarbamido - 3 - methyl - 4 - (o-carboxyphenylazo) - 5 - pyrazolone ; 1:1 - (carbethoxy) (o-carboxyphenylazo) - acetonethiosemicarbazone; 1 - acetyl - 4 - phenylazothiohydantoin; 1 - (benztriazole - 41 - azo) - 2 - hydroxy - 3 - aminophenazine ; 1 - (o-carboxyphenylazo) - 2 - hydroxy - 3 - aminophenazine ; 4 - nitro - 2 - (benztriazole - 4<SP>1</SP> - azo) - phenol ; phenylazorhodanine; N-(thioacetyl)-2-hydroxy- 5-(o-carboxyphenylazo)-aniline ; and 5-(p-hydroxybenzylidene) - rhodanine. Specification 475,786 also is referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2671023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2573027-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2668113-A
priorityDate 1938-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154137733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413814235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421972151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1274030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431941772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420924944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450864287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID120189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420233205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425199706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432433117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453530231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449731539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12531337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419765446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2796939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154286163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420230302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154278216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23661981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432329400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432000636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154344856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431982584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID707035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416116235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407608385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431956303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159497965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136823319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432055508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154100108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154117821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432031708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID498427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408795568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154147599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432315520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154106597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412753460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416199102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450754681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447582325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448774721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129785204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432266599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004

Total number of triples: 134.